Literature DB >> 1914116

Proarrhythmic effects of flecainide. Experimental evidence for increased susceptibility to reentrant arrhythmias.

J Brugada1, L Boersma, C Kirchhof, M Allessie.   

Abstract

BACKGROUND: The goal of this study was to investigate the nature and electrophysiological mechanisms of the proarrhythmic effects of flecainide in Langendorff-perfused rabbit hearts. METHODS AND
RESULTS: A thin layer of epicardium was obtained by an endocardial cryotechnique in 10 Langendorff-perfused rabbit hearts. Six other hearts were kept intact. Programmed electrical stimulation using up to three closely coupled premature stimuli and burst pacing was used to test the inducibility of arrhythmias both during control and administration of 1 micrograms/ml flecainide. During control, in the thin layer of epicardium, application of one to three premature stimuli induced nonsustained ventricular tachycardia in out of 10 hearts, and burst pacing induced nonsustained ventricular tachycardia in four hearts and sustained ventricular tachycardia in two hearts. During administration of 1 microgram/ml flecainide, application of one to three premature stimuli induced sustained ventricular tachycardia in five hearts, and burst pacing induced sustained ventricular tachycardia in nine hearts. All tachycardias were based on circus movement of the impulse around arcs of functional block. During administration of flecainide, different locations of the arc of block could be found in the same heart, leading to different reentrant circuits with different cycle lengths. In the control group of six intact hearts, application of up to three closely coupled premature stimuli in all cases induced ventricular fibrillation both during control and administration of flecainide.
CONCLUSIONS: Flecainide alters propagation of the impulse in thin surviving layers of myocardium in a manner that facilitates the induction of functionally determined reentry.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1914116     DOI: 10.1161/01.cir.84.4.1808

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  9 in total

Review 1.  Subclassification of class I antiarrhythmic drugs: enhanced relevance after CAST.

Authors:  T J Campbell
Journal:  Cardiovasc Drugs Ther       Date:  1992-10       Impact factor: 3.727

2.  Predicting drug-induced slowing of conduction and pro-arrhythmia: identifying the 'bad' sodium current blockers.

Authors:  Hua Rong Lu; Jutta Rohrbacher; Eddy Vlaminckx; Karel Van Ammel; Gan-Xin Yan; David J Gallacher
Journal:  Br J Pharmacol       Date:  2010-03-22       Impact factor: 8.739

3.  Arrhythmogenicity of antiarrhythmic drugs and intraventricular conduction disorders: possible aggravation by myocardial ischemia--study in the porcine in situ heart.

Authors:  J F Aupetit; Q Timour; J P Larbre; J Loufoua-Moundanga; I Kioueh; M Lopez; G Faucon
Journal:  Cardiovasc Drugs Ther       Date:  1993-04       Impact factor: 3.727

4.  Effects of hyperkalaemia on the depression of maximum rate of depolarization by class I antiarrhythmic agents in guinea-pig myocardium.

Authors:  K R Wyse; V Ye; T J Campbell
Journal:  Br J Pharmacol       Date:  1993-01       Impact factor: 8.739

5.  Flecainide-induced Increase in QRS Duration and Proarrhythmia during Exercise.

Authors:  P Bordier; S Garrigue; V Bernard; M Haissaguerre; H Douard; J P Broustet; J Clementy
Journal:  Clin Drug Investig       Date:  1997-06       Impact factor: 2.859

6.  Flecainide exerts paradoxical effects on sodium currents and atrial arrhythmia in murine RyR2-P2328S hearts.

Authors:  S C Salvage; J H King; K H Chandrasekharan; D I G Jafferji; L Guzadhur; H R Matthews; C L-H Huang; J A Fraser
Journal:  Acta Physiol (Oxf)       Date:  2015-04-23       Impact factor: 6.311

7.  Management of life-threatening flecainide overdose: A case report and review of the literature.

Authors:  Nancy M Vu; Terence E Hill; Matthew R Summers; Michael N Vranian; Michael D Faulx
Journal:  HeartRhythm Case Rep       Date:  2015-12-29

8.  Time-dependent antiarrhythmic effects of flecainide on induced atrial fibrillation in horses.

Authors:  Helena Carstensen; Eva Z Hesselkilde; Merle Fenner; Ameli V Loft-Andersen; Mette Flethøj; Jørgen K Kanters; Stefan M Sattler; Jacob Tfelt-Hansen; Steen Pehrson; Thomas Jespersen; Rikke Buhl
Journal:  J Vet Intern Med       Date:  2018-08-22       Impact factor: 3.333

9.  QT interval prolongation and torsade de pointes: Synergistic effect of flecainide and H1 receptor antagonists.

Authors:  Carlos Acosta-Materán; Eloy Díaz-Oliva; Diego Fernández-Rodríguez; Julio Hernández-Afonso
Journal:  J Pharmacol Pharmacother       Date:  2016 Apr-Jun
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.